Poxviral vectors for cancer immunother… [Expert Opin Biol Ther. 2012]

Via Scoop.itVirology and Bioinformatics from Virology.ca

Poxviral vaccines have been given to over 1 billion people in the successful global eradication of smallpox. Recombinant poxviruses have been investigated extensively as a novel immunotherapy for cancer, undergoing several iterations to optimize their immunogenicity and efficacy.

Via www.ncbi.nlm.nih.gov

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.